Nouscom will present at the NeoAg Summit 2018

The 3rd NeoAg Summit is the leading end-to-end industry- focused meeting dedicated to advancing neoantigen-based cancer vaccines and cell therapies. Download the full program of NeoAg Summit 2018.

Nouscom Strengthens Board of Directors with the Appointment of John F. McDonald as an Independent Director

BASEL, Switzerland – 5th November 2018 Nouscom, an immuno-oncology company developing off-the-shelf and personalized neoantigen-based genetic cancer vaccines based on its proprietary technology [...]